Herein, we propose that a novel type of nanocarrier, C-type natriuretic peptide-modified lipid vesicles, can be used to transport anticancer drugs across the BBB, and then eliminate brain glioma and destroy neovasculatures. This evidence concerns the gene NPPC and brain glioma.